Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CXCR3 | P49682 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7991194 | 0.98 | SMN1; SMN2 (0.45) | SMN1; SMN2ALDH1A1ALOX15MAPK1CXCR3 | |
| SCHEMBL7595037 | 0.93 | — | — | |
| SCHEMBL10484735 | 0.83 | SMN1; SMN2 (0.37) | SMN1; SMN2ALDH1A1ALOX15MAPK1CXCR3 | |
| SCHEMBL23004916 | 0.83 | SMN1; SMN2 (0.41) | SMN1; SMN2ALDH1A1ALOX15MAPK1CXCR3 | |
| SCHEMBL14731953 | 0.83 | SMN1; SMN2 (0.44) | SMN1; SMN2ALDH1A1ALOX15MAPK1CXCR3 | |
| SCHEMBL23004914 | 0.83 | SMN1; SMN2 (0.41) | SMN1; SMN2ALDH1A1ALOX15MAPK1CXCR3 | |
| SCHEMBL23004945 | 0.83 | SMN1; SMN2 (0.41) | SMN1; SMN2ALDH1A1ALOX15MAPK1CXCR3 | |
| SCHEMBL205150 | 0.81 | KMT2A (0.40) | SMN1; SMN2ALDH1A1ALOX15MAPK1CXCR3 | |
| SCHEMBL21955625 | 0.80 | — | — | |
| SCHEMBL6940115 | 0.78 | SMN1; SMN2 (0.59) | SMN1; SMN2ALDH1A1ALOX15MAPK1PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117105799-A | Synthesis method of dihydrocapsaicin | 苏州华道生物药业股份有限公司 | 2023-11-24 | — | — | CN | claimed |
| EP-2046147-B1 | METHOD OF USING ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2013-05-01 | — | — | EP | claimed |
| US-20090311403-A1 | Method of Using Organic Compounds | GIVAUDAN SA (CH) | 2009-12-17 | — | — | US | claimed |
| EP-2046147-A1 | METHOD OF USING ORGANIC COMPOUNDS | Givaudan SA (CH) | 2009-04-15 | — | — | EP | claimed |
| WO-2008011742-A1 | METHOD OF USING ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2008-01-31 | — | — | WO | claimed |
| CN-117105799-B | Dihydro chilli Process for synthesizing alkali | 苏州华道生物药业股份有限公司 | 2025-06-06 | — | — | CN | disclosed |
| CN-118255947-A | (Meth) acrylic acid copolymer and method for producing same | 日铁化学材料株式会社 | 2024-06-28 | — | — | CN | disclosed |
| CN-118256177-A | Composition for forming adhesive layer, laminate, method for producing adhesive layer, method for producing laminate, and method for treating laminate | 日铁化学材料株式会社 | 2024-06-28 | — | — | CN | disclosed |
| CN-117105799-A | Synthesis method of dihydrocapsaicin | 苏州华道生物药业股份有限公司 | 2023-11-24 | — | — | CN | disclosed |
| CN-117105799-A | Synthesis method of dihydrocapsaicin | 苏州华道生物药业股份有限公司 | 2023-11-24 | — | — | CN | disclosed |
| CN-113861343-B | Urethane (meth) acrylate, active energy ray-curable resin composition, cured product, and laminate | 荒川化学工业株式会社 | 2023-11-10 | — | — | CN | disclosed |
| CN-116893576-A | Positive resist material and pattern forming method | 信越化学工业株式会社 | 2023-10-17 | — | — | CN | disclosed |
| US-5977062-A | ACTIVE AGAINST ANTIBIOTIC RESISTANT BACTERIA | ELI LILLY AND COMPANY (US) | 1999-11-02 | — | — | US | disclosed |
| US-5942580-A | COMPRISING A HALOGEN CONTAINING ARYLIC RUBBER, A VULCANIZING AGENT AND ATLEAST ONE UNSATURATED COMPOUND SELECTED FROM CARBOXYLIC ACID VINYL ESTERS, ALKYL VINYL ETHERS, LOWER ALKYL CYCLOHEXANES OR CYCLOHEXENECARBOXYLIC ACID CAPROLACTONE ESTER | NIPPON MEKTRON, LIMITED (JP) | 1999-08-24 | — | — | US | disclosed |
| EP-0738758-A2 | Acrylic rubber composition | NIPPON MEKTRON, LTD. (JP) | 1996-10-23 | — | — | EP | disclosed |
| EP-0282312-B1 | PROCESS FOR THE PRODUCTION OF AN ISOBUTYLBENZENE FROM AN ISOBUTENYLCYCLOHEXENE | BP Chemicals Limited (GB) | 1991-08-21 | — | — | EP | disclosed |
| US-4827070-A | DEHYDROISOMERIZATION WITH CATALYST IN PRESENCE OF OXYGEN FOR BY-PRODUCT INHIBITION | BP CHEMICALS LIMITED (GB) | 1989-05-02 | — | — | US | disclosed |
| EP-0282312-A1 | Process for the production of an isobutylbenzene from an isobutenylcyclohexene | BP Chemicals Limited (GB) | 1988-09-14 | — | — | EP | disclosed |
| US-3868411-A | Isobutyl cyclohexenyl compounds alpha (p-isobutyl-cyclohexenyl) alkanoic acids | EN NOM COLLECTIF SCIENCE UNION | 1975-02-25 | — | — | US | disclosed |
| US-3868411-A | Isobutyl cyclohexenyl compounds alpha (p-isobutyl-cyclohexenyl) alkanoic acids | EN NOM COLLECTIF SCIENCE UNION | 1975-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090311403-A1 | Method of Using Organic Compounds | MGLL, GK, LIPC | SMN1; SMN2 2299/4885ALDH1A1 788/4885ALOX15 448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.